Managing Pseudophakic Corneal Edema: Structural Changes and Preliminary Observations on Coenzyme Q10 Use
Umay Güvenç1, Züleyha Yalnız Akkaya1, Ayşe Burcu1
1Department of Ophthalmology, Ankara Training and Research Hospital, Ankara, Turkiye.
Korean Journal of Ophthalmology : KJO
|June 16, 2025
Summary
Pseudophakic corneal edema (PCE) can delay vision recovery after cataract surgery. Coenzyme Q10 (CoQ10) may speed up corneal healing and improve outcomes in patients with pseudophakic corneal edema.
Area of Science:
- Ophthalmology
- Corneal Surgery
- Biochemistry
Background:
- Pseudophakic corneal edema (PCE) is a common postoperative complication after cataract surgery.
- It can significantly impact visual recovery and refractive results.
- Understanding the factors influencing PCE resolution is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the relationship between keratometric and pachymetric changes during PCE resolution.
- To evaluate factors influencing the resolution of pseudophakic corneal edema.
- To examine the efficacy of coenzyme Q10 (CoQ10) as an adjunct therapy for PCE.
Main Methods:
- Retrospective analysis of 88 patients aged 50+ who developed PCE post-phacoemulsification.
- Corneal assessments using Pentacam HR for keratometric and pachymetric changes.
- Weekly monitoring until PCE resolution; subset received CoQ10 adjunct therapy.
Main Results:
- Significant improvement in visual acuity (p < 0.001).
- Persistent keratometric changes (posterior steepening, anterior asphericity) despite pachymetric normalization.
- CoQ10 group showed faster edema resolution (p = 0.019), reduced corneal thickness (p = 0.003), and improved transparency.
- Higher cumulative dissipated energy linked to increased edema severity and slower recovery.
- Diabetes prolonged recovery (p = 0.018).
Conclusions:
- Visual acuity and pachymetry improved, but persistent topographic changes indicate incomplete structural normalization.
- Adjunctive CoQ10 may enhance corneal edema resolution, leading to faster recovery and favorable structural changes.
- Further prospective studies are needed to validate these findings.
More Related Videos
Related Concept Videos
Angle Closure Glaucoma: Treatment
718
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
718
Open Angle Glaucoma: Treatment
597
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
597
Glaucoma: Overview
792
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
792
Nephrotic Syndrome II : Assessment and Medical Management
26
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
26
Nephrotic Syndrome III : Nursing Management
51
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
51
Rheumatic Heart Disease III: Medical Management
36
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
36


